Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07399977 · ClinicalTrials.gov registry record · NA
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
A NA study of Venous Thromboembolism and Deep Venous Thrombosis, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 259
- Enrollment target
- 8
- Study locations
NCT07399977: Recruiting NA study of Venous Thromboembolism and Deep Venous Thrombosis, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07399977 is a NA study of Venous Thromboembolism and Deep Venous Thrombosis that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 259 participants, below the 6,290-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (96% lower). The trial reports 8 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07399977, a NA study of Venous Thromboembolism and Deep Venous Thrombosis, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 259 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to find out whether a software tool, ctDNA/VTE (Venous Thromboembolism) risk score model, is an effective way to predict the likelihood of VTE coming back in people who have received anticoagulant treatment.
Primary Outcome
Evaluate the cumulative incidence of recurrent Venous Thromboembolism/VTE at 6 months following discontinuation of anticoagulation in participants with low risk DNA liquid biopsy-based model.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST MSK-ACCESS
- DIAGNOSTIC_TEST ctDNA/VTE Risk Score:
Study Locations (8)
New York
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activites) - New York
- Memorial Sloan Kettering Nassau (All protocol activities) - Rockville Centre
New Jersey
- Memorial Sloan Kettering Cancer Center Basking Ridge (All Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities) - Montvale
Other
- Royal North Shore Hospital, Australia - Sydney
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2026-01-30 |
| Est. Completion | 2030-01-30 |
| Phase | NA |
What NCT07399977 shows while recruiting
NCT07399977 is an interventional study that assigns participants to a tested intervention. The registered 259 participants enrollment target is mid-sized for trials with a published cap, below the 6,290-participant average among 47 other Venous Thromboembolism trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Venous Thromboembolism appearing as the primary indexed condition, and to 2 interventions - of which MSK-ACCESS is the first listed.
NCT07399977 lists 8 locations in 3 states (New York, New Jersey, Other).
Frequently Asked Questions
What is clinical trial NCT07399977 about?
NCT07399977 is a clinical study titled "Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism". The purpose of this study is to find out whether a software tool, ctDNA/VTE (Venous Thromboembolism) risk score model, is an effective way to predict the likelihood of VTE coming back in people who have received anticoagulant treatment.
What is the current status of trial NCT07399977?
This trial is currently recruiting. It is a NA study. The enrollment target is 259 participants. The study started on 2026-01-30. Estimated completion is 2030-01-30.
What conditions does trial NCT07399977 study?
This clinical trial studies the following conditions: Venous Thromboembolism, Deep Venous Thrombosis.
What interventions are being tested in trial NCT07399977?
The interventions under investigation include: MSK-ACCESS (DIAGNOSTIC_TEST), ctDNA/VTE Risk Score: (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07399977?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07399977 being conducted?
This trial has 8 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thromboembolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07399977's enrollment target sits among peer trials
259 30th of 47 higher than 18 of 47 other Venous Thromboembolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Thromboembolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
RECRUITING · NA
-
Warfarin Patient Self-management Implementation in the US Healthcare System
RECRUITING · NA
-
CLEANer Aspiration for Pulmonary Embolism
RECRUITING · NA
-
Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02361320 · 259 participants · NA
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
- NCT06797258 · 259 participants · NA
FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction
- NCT06990425 · 259 participants · NA
CLOSM Trial: Groin Closure Using Layered Option for Suture Material
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI